| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 166.44M | 196.95M | 192.45M | 133.04M | 120.90M |
| Gross Profit | 44.51M | 83.39M | 102.05M | 118.61M | 101.86M |
| EBITDA | -18.30M | 26.52M | 40.90M | 63.75M | 50.48M |
| Net Income | -12.53M | 18.62M | 29.48M | 45.58M | 34.24M |
Balance Sheet | |||||
| Total Assets | 3.28B | 3.60B | 3.83B | 3.55B | 2.97B |
| Cash, Cash Equivalents and Short-Term Investments | 140.19M | 318.02M | 279.52M | 321.81M | 497.55M |
| Total Debt | 300.49M | 511.46M | 523.75M | 433.63M | 121.74M |
| Total Liabilities | 2.98B | 3.28B | 3.52B | 3.25B | 2.69B |
| Stockholders Equity | 304.28M | 323.93M | 314.06M | 291.25M | 274.02M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 66.50M | 30.63M | 40.37M | 45.57M |
| Operating Cash Flow | 0.00 | 67.73M | 35.16M | 40.89M | 45.89M |
| Investing Cash Flow | 0.00 | 222.77M | -233.32M | -761.50M | -7.67M |
| Financing Cash Flow | 0.00 | -252.74M | 248.33M | 538.34M | 112.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $191.59M | 15.57 | 8.41% | 4.66% | -2.00% | -36.25% | |
75 Outperform | $169.41M | 9.08 | 11.72% | 3.01% | 12.31% | 39.46% | |
70 Outperform | $177.55M | 12.59 | 7.00% | 2.00% | -2.16% | -9.35% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | $141.25M | -2.23 | -24.07% | 0.84% | 1.33% | -593.24% | |
60 Neutral | $171.29M | 12.64 | -2.07% | 1.90% | 1.92% | -174.59% | |
56 Neutral | $145.23M | -10.05 | 0.86% | 7.74% | -8.73% | -95.86% |
On January 30, 2026, BCB Bancorp reported a net loss of $12.0 million for the fourth quarter of 2025, reversing a profit of $4.3 million in the prior quarter and $3.3 million a year earlier, as results were hit by a $15.1 million pre-tax write-down on an isolated cannabis-related real estate owned property and $16.3 million in additional net charge-offs, mainly in its commercial and industrial loan portfolio. The loss drove annualized returns on average assets and equity to negative 1.44% and 15.0%, respectively, and pushed the fourth-quarter efficiency ratio to 120.0%, even as net interest margin improved to 3.03% on a lower cost of interest-bearing liabilities and a largely stable asset yield. Over 2025 the company shrank its balance sheet by 8.9% to $3.28 billion, reducing loans by 10.2%, cutting higher-cost brokered deposits and FHLB advances, and modestly increasing its investment portfolio as part of a strategic effort to bolster capital ratios and improve asset quality; non-accrual loans fell sequentially to $63.3 million, while the allowance for credit losses stood at 1.24% of gross loans and 53.3% of non-accruals. Despite the pressure on earnings and a $19.6 million decline in shareholders’ equity, the board maintained a regular quarterly cash dividend, albeit at a reduced level of $0.08 per share payable on February 26, 2026, signaling a recalibrated but ongoing commitment to shareholder returns while prioritizing prudent capital and balance-sheet management.
The most recent analyst rating on (BCBP) stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on BCB Bancorp stock, see the BCBP Stock Forecast page.
On January 13, 2026, BCB Bancorp, Inc. announced that it had determined an additional pre-tax write-down of $15.1 million was required on an isolated cannabis-related real estate owned property, following earlier actions in 2025 that included a specific reserve in the first quarter and a $12.7 million charge-off when the loan was moved to REO in the third quarter. The company also disclosed that its fourth quarter 2025 financial statements will reflect a further $16.4 million in net charge-offs, largely tied to its C&I loan portfolio, including a single $6.4 million C&I loan and about $1.4 million from “Business Express” loans, while emphasizing that its capital position is sufficient to absorb these losses without materially affecting ongoing operations and that these charges are not expected to require future cash outlays, ahead of its scheduled release of full fourth quarter 2025 results on January 30, 2026.
The most recent analyst rating on (BCBP) stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on BCB Bancorp stock, see the BCBP Stock Forecast page.
On January 7, 2026, BCB Bancorp announced that Raymond J. Vanaria had informed the company of his retirement from its Board of Directors, effective December 31, 2025. The board publicly acknowledged and expressed appreciation for Vanaria’s service to the company and its shareholders, marking a planned change in board composition at the end of 2025.
The most recent analyst rating on (BCBP) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on BCB Bancorp stock, see the BCBP Stock Forecast page.